<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05061329</url>
  </required_header>
  <id_info>
    <org_study_id>NasalMicrobiomeTO,LD,KF</org_study_id>
    <nct_id>NCT05061329</nct_id>
  </id_info>
  <brief_title>The Nasal Microbiome and Its Importance in Disease</brief_title>
  <official_title>The Importance of the Nasal Microbiome in Transmission and Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this exploratory, hypothesis-generating study is to investigate the composition of&#xD;
      the nasal microbiome in order to compare 1: COVID-positive and negative individuals, 2.&#xD;
      Patients with smell loss and controls without smell loss; and 3. patients using intranasal&#xD;
      glucocorticoids and non-users.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypotheses:&#xD;
&#xD;
      The nasal microbiome in COVID-positive patients does not differ from healthy COVID-negative&#xD;
      patients.&#xD;
&#xD;
      The nasal microbiome in patients suffering from post COVID-19 olfactory dysfunction does not&#xD;
      differ from healthy controls with normal olfaction.&#xD;
&#xD;
      The nasal microbiome in non-COVID-patients with anosmia does not differ from non-COVID&#xD;
      controls with normal sense of smell.&#xD;
&#xD;
      Intra-nasal glucocorticoids do not affect the nasal microbiome.&#xD;
&#xD;
      Methods:&#xD;
&#xD;
      For all patients we will obtain a relevant medical history; an ear-, nose-, and throat&#xD;
      examination; Sino-Nasal Outcome Test-22, score; Sniffin' Sticks TDI score; and taste&#xD;
      screening results.&#xD;
&#xD;
      The microbiome will be evaluated using swabs from the nasal cavity and analysed using&#xD;
      next-generation sequencing targeting 16S and 18S ribosomal RNA at the Department of Bacteria,&#xD;
      Parasite &amp; Fungi at Staten Serum Institute, Copenhagen, Denmark.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 21, 2020</start_date>
  <completion_date type="Anticipated">September 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>Microbiome difference</measure>
    <time_frame>6 months</time_frame>
    <description>Difference in microbiome between the defined groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of nasal glucocorticoids on nasal microbiome</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between TDI score and nasal microbiome</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">320</enrollment>
  <condition>Nasal Microbiome, COVID-19</condition>
  <arm_group>
    <arm_group_label>Normal individuals</arm_group_label>
    <description>no sino-nasal disease - no upper airway allergies - no intra nasal medication - normal sense of smell</description>
  </arm_group>
  <arm_group>
    <arm_group_label>COVID-19 positive patient</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Post-COVID-19 patients</arm_group_label>
    <description>Previous COVID-19 positive patients with prolonged olfactory dysfunction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with chronic rhinosinusitis with and without nasal polyps</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with smell loss</arm_group_label>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Microbiome swabs&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        1. Normal individuals: no sino-nasal disease - no upper airway allergies - no intra nasal&#xD;
             medication - normal sense of smell&#xD;
&#xD;
          2. Patients with smell loss&#xD;
&#xD;
          3. COVID-19 positive patients&#xD;
&#xD;
          4. Previous COVID-19 positive patients with prolonged olfactory dysfunction&#xD;
&#xD;
          5. Patients with chronic rhinosinusitis with and without nasal polyps&#xD;
&#xD;
        Recruitment: population 1, 5, and 6 are recruited among patients undergoing surgery at the&#xD;
        ENT department, Regional Hospital West Jutland, Denmark. Populations 2 and 4 are enrolled&#xD;
        from the Flavour Clinic, ENT department, Regional Hospital Denmark. Population 3 is&#xD;
        recruited at the COVID-19 clinics in Aarhus and Herning. Population 1 will be supplied with&#xD;
        staff members and university students.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Does not wish to participate in study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laura Marie Aalkjær Danielsen</last_name>
    <role>Principal Investigator</role>
    <affiliation>student</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laura Marie Aalkjær Danielsen</last_name>
    <phone>+4542714748</phone>
    <email>lauraaalkjaer@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Therese Ovesen, MD</last_name>
    <phone>53800777</phone>
    <email>theroves@rm.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ear, Nose and Throat Department, HEV</name>
      <address>
        <city>Holstebro</city>
        <state>Midtjylland</state>
        <zip>7500</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Danielsen</last_name>
      <phone>+4542714748</phone>
      <email>lauraaalkjaer@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 21, 2021</study_first_submitted>
  <study_first_submitted_qc>September 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 29, 2021</study_first_posted>
  <last_update_submitted>September 21, 2021</last_update_submitted>
  <last_update_submitted_qc>September 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

